SC 13D Filing

Company

Anixa Biosciences Inc

Filed

May 3, 2024

Accession Number

0001493152-24-017664

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →